Mineralys Therapeutics, Inc. (MLYS)
Market Closed
12 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
23. 62
-0.32
-1.3367%
$
1.57B Market Cap
- P/E Ratio
- Div Yield
1.8M Volume
-2.58 Eps
$ 23.94
Previous Close 
Want to track MLYS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mineralys Therapeutics, Inc. (MLYS) Statistics
Valuation metrics
Market Cap 1.57B
Enterprise value 1.45B
Trailing P/E (ttm) -12.89
Forward P/E -
PEG ratio -0.19
Price/Sales (ttm) -
Price/Book (mrq) 3.07
Enterprise Value/Revenue -
Enterprise Value/EBITDA -9.58
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.66M
Average volume (90 days) 1.26M
Price summary
52-Week low 12.59
52-Week high 47.65
Beta -
50-Day moving average 28.18
200-Day moving average 30.71
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.23%
Return on equity -0.28%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.8
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 44.33%
Book value per share (mrq) 7.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
